Moreover, our study revealed that 4 somatically mutated genes, including CSPG4, DNAH11, INADL and TMPRSS13, might act as promising predictive factors of PD-L1-positive expression in RCC tumor cells. This evidence concerns the gene CD274 and renal cell carcinoma.